164 related articles for article (PubMed ID: 12485205)
1. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
McCall RB; Huff R; Chio CL; TenBrink R; Bergh CL; Ennis MD; Ghazal NB; Hoffman RL; Meisheri K; Higdon NR; Hall E
Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
[TBL] [Abstract][Full Text] [Related]
2. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
[TBL] [Abstract][Full Text] [Related]
3. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C
Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423
[TBL] [Abstract][Full Text] [Related]
4. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Muñoz-Islas E; Gupta S; Jiménez-Mena LR; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
Br J Pharmacol; 2006 Sep; 149(1):82-91. PubMed ID: 16880765
[TBL] [Abstract][Full Text] [Related]
5. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
Bouchelet I; Case B; Olivier A; Hamel E
Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
[TBL] [Abstract][Full Text] [Related]
6. Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Muñoz-Islas E; Lozano-Cuenca J; González-Hernández A; Ramírez-Rosas MB; Sánchez-López A; Centurión D; Maassenvandenbrink A; Villalón CM
Eur J Pharmacol; 2009 Aug; 615(1-3):133-8. PubMed ID: 19460365
[TBL] [Abstract][Full Text] [Related]
7. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine.
Gras J; Cardelús I; Llenas J; Palacios JM
Eur J Pharmacol; 2000 Dec; 410(1):53-9. PubMed ID: 11134656
[TBL] [Abstract][Full Text] [Related]
9. Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.
Barbanti P; Aurilia C; Egeo G; Fofi L; Palmirotta R
Expert Opin Investig Drugs; 2017 Mar; 26(3):269-277. PubMed ID: 28103158
[TBL] [Abstract][Full Text] [Related]
10. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs.
Parsons AA; Parker SG; Raval P; Campbell CA; Lewis VA; Griffiths R; Hunter AJ; Hamilton TC; King FD
J Cardiovasc Pharmacol; 1997 Jul; 30(1):136-41. PubMed ID: 9268233
[TBL] [Abstract][Full Text] [Related]
13. Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.
Ennis MD; Ghazal NB; Hoffman RL; Smith MW; Schlachter SK; Lawson CF; Im WB; Pregenzer JF; Svensson KA; Lewis RA; Hall ED; Sutter DM; Harris LT; McCall RB
J Med Chem; 1998 Jun; 41(13):2180-3. PubMed ID: 9632349
[No Abstract] [Full Text] [Related]
14. Migraine: pathophysiology, pharmacology, treatment and future trends.
Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
[TBL] [Abstract][Full Text] [Related]
15. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
[TBL] [Abstract][Full Text] [Related]
16. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
[TBL] [Abstract][Full Text] [Related]
17. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
18. Re: Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia 2001;21:727-32.
Ferrari MD
Cephalalgia; 2001 Sep; 21(7):711. PubMed ID: 11603382
[No Abstract] [Full Text] [Related]
19. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain.
Pascual J; del Arco C; Romón T; del Olmo E; Castro E; Pazos A
Cephalalgia; 1996 Aug; 16(5):317-22. PubMed ID: 8869766
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine.
Gomez-Mancilla B; Cutler NR; Leibowitz MT; Spierings EL; Klapper JA; Diamond S; Goldstein J; Smith T; Couch JR; Fleishaker J; Azie N; Blunt DE
Cephalalgia; 2001 Sep; 21(7):727-32. PubMed ID: 11595000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]